Pregled bibliografske jedinice broj: 1260819
Non-coding variants disrupting a tissue-specific regulatory element in HK1 cause congenital hyperinsulinism
Non-coding variants disrupting a tissue-specific regulatory element in HK1 cause congenital hyperinsulinism // Nature genetics, 54 (2022), 11; 1615-1620 doi:10.1038/s41588-022-01204-x (međunarodna recenzija, članak, znanstveni)
CROSBI ID: 1260819 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Non-coding variants disrupting a tissue-specific
regulatory element in HK1 cause congenital
hyperinsulinism
Autori
Wakeling, Matthew N. ; Owens, Nick D. L. ; Hopkinson, Jessica R. ; Johnson, Matthew B. ; Houghton, Jayne A. L. ; Dastamani, Antonia ; Flaxman, Christine S. ; Wyatt, Rebecca C. ; Hewat, Thomas I. ; Hopkins, Jasmin J. ; Laver, Thomas W. ; van Heugten, Rachel ; Weedon, Michael N. ; De Franco, Elisa ; Patel, Kashyap A. ; Ellard, Sian ; Morgan, Noel G. ; Cheesman, Edmund ; Banerjee, Indraneel ; Hattersley, Andrew T. ; Dunne, Mark J. ; Richardson, Sarah J. ; Flanagan, Sarah E.
Kolaboracija
International Congenital Hyperinsulinism Consortium
Izvornik
Nature genetics (1061-4036) 54
(2022), 11;
1615-1620
Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, znanstveni
Ključne riječi
congenital hyperinsulinism ; HK1 gene
Sažetak
Gene expression is tightly regulated, with many genes exhibiting cell-specific silencing when their protein product would disrupt normal cellular function. This silencing is largely controlled by non-coding elements, and their disruption might cause human disease. We performed gene-agnostic screening of the non-coding regions to discover new molecular causes of congenital hyperinsulinism. This identified 14 non-coding de novo variants affecting a 42-bp conserved region encompassed by a regulatory element in intron 2 of the hexokinase 1 gene (HK1). HK1 is widely expressed across all tissues except in the liver and pancreatic beta cells and is thus termed a 'disallowed gene' in these specific tissues. We demonstrated that the variants result in a loss of repression of HK1 in pancreatic beta cells, thereby causing insulin secretion and congenital hyperinsulinism. Using epigenomic data accessed from public repositories, we demonstrated that these variants reside within a regulatory region that we determine to be critical for cell-specific silencing. Importantly, this has revealed a disease mechanism for non-coding variants that cause inappropriate expression of a disallowed gene.
Izvorni jezik
Engleski
Znanstvena područja
Kliničke medicinske znanosti
POVEZANOST RADA
Ustanove:
Medicinski fakultet, Zagreb,
Klinički bolnički centar Zagreb
Profili:
Ivo Barić
(autor)
Citiraj ovu publikaciju:
Časopis indeksira:
- Current Contents Connect (CCC)
- Web of Science Core Collection (WoSCC)
- Science Citation Index Expanded (SCI-EXP)
- SCI-EXP, SSCI i/ili A&HCI
- Scopus
- MEDLINE
- Nature Index